BioRestorative Therapies Announces Closing of $23 Million Public Offering
November 09, 2021 14:20 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced...
BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
October 26, 2021 16:05 ET
|
BioRestorative Therapies, Inc
MELVILLE, NY, Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BRTX” or the “Company”) (OTC: BRTX), a life sciences company focused on adult stem cell-based therapies, today...
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
October 26, 2021 08:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
September 23, 2021 09:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Sept. 23, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
August 19, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Discusses Upcoming Annual Meeting of Stockholders
August 11, 2021 08:30 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 11, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021
June 07, 2021 06:00 ET
|
BioRestorative Therapies, Inc
BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference. ...
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 10, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...